학술논문

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Document Type
article
Author
Meyer, Kerstin BO'Reilly, MartinMichailidou, KyriakiCarlebur, SaskiaEdwards, Stacey LFrench, Juliet DPrathalingham, RadhikaDennis, JoeBolla, Manjeet KWang, Qinde Santiago, InesHopper, John LTsimiklis, HelenApicella, CarmelSouthey, Melissa CSchmidt, Marjanka KBroeks, AnnegienVan 't Veer, Laura JHogervorst, Frans BMuir, KennethLophatananon, ArtitayaStewart-Brown, SarahSiriwanarangsan, PornthepFasching, Peter ALux, Michael PEkici, Arif BBeckmann, Matthias WPeto, JulianDos Santos Silva, IsabelFletcher, OliviaJohnson, NicholaSawyer, Elinor JTomlinson, IanKerin, Michael JMiller, NicolaMarme, FederickSchneeweiss, AndreasSohn, ChristofBurwinkel, BarbaraGuénel, PascalTruong, ThérèseLaurent-Puig, PierreMenegaux, FlorenceBojesen, Stig ENordestgaard, Børge GNielsen, Sune FFlyger, HenrikMilne, Roger LZamora, M PilarArias, Jose IBenitez, JavierNeuhausen, SusanAnton-Culver, HodaZiogas, ArgyriosDur, Christina CBrenner, HermannMüller, HeikoArndt, VolkerStegmaier, ChristaMeindl, AlfonsSchmutzler, Rita KEngel, ChristophDitsch, NinaBrauch, HiltrudBrüning, ThomasKo, Yon-DschunGENICA NetworkNevanlinna, HeliMuranen, Taru AAittomäki, KristiinaBlomqvist, CarlMatsuo, KeitaroIto, HidemiIwata, HirojiYatabe, YasushiDörk, ThiloHelbig, SonjaBogdanova, Natalia VLindblom, AnnikaMargolin, SaraMannermaa, ArtoKataja, VesaKosma, Veli-MattiHartikainen, Jaana MChenevix-Trench, GeorgiakConFab InvestigatorsAustralian Ovarian Cancer Study GroupWu, Anna HTseng, Chiu-ChenVan Den Berg, DavidStram, Daniel OLambrechts, DietherThienpont, BernardChristiaens, Marie-RoseSmeets, AnnChang-Claude, JennyRudolph, AnjaSeibold, PetraFlesch-Janys, DieterRadice, Paolo
Source
American journal of human genetics. 93(6)
Subject
GENICA Network
kConFab Investigators
Australian Ovarian Cancer Study Group
Cell Line
Tumor
Humans
Breast Neoplasms
Case-Control Studies
Chromatin Immunoprecipitation
Chromosome Mapping
Gene Expression Regulation
Neoplastic
RNA Interference
Binding Sites
Protein Binding
Haplotypes
Alleles
Female
E2F1 Transcription Factor
Receptor
Fibroblast Growth Factor
Type 2
Hepatocyte Nuclear Factor 3-alpha
Promoter Regions
Genetic
Genetic Loci
Position-Specific Scoring Matrices
Genetic Association Studies
Asian People
White People
Black People
Cancer
Human Genome
Breast Cancer
Genetics
Prevention
2.1 Biological and endogenous factors
Aetiology
Biological Sciences
Medical and Health Sciences
Genetics & Heredity
Language
Abstract
The 10q26 locus in the second intron of FGFR2 is the locus most strongly associated with estrogen-receptor-positive breast cancer in genome-wide association studies. We conducted fine-scale mapping in case-control studies genotyped with a custom chip (iCOGS), comprising 41 studies (n = 89,050) of European ancestry, 9 Asian ancestry studies (n = 13,983), and 2 African ancestry studies (n = 2,028) from the Breast Cancer Association Consortium. We identified three statistically independent risk signals within the locus. Within risk signals 1 and 3, genetic analysis identified five and two variants, respectively, highly correlated with the most strongly associated SNPs. By using a combination of genetic fine mapping, data on DNase hypersensitivity, and electrophoretic mobility shift assays to study protein-DNA binding, we identified rs35054928, rs2981578, and rs45631563 as putative functional SNPs. Chromatin immunoprecipitation showed that FOXA1 preferentially bound to the risk-associated allele (C) of rs2981578 and was able to recruit ERα to this site in an allele-specific manner, whereas E2F1 preferentially bound the risk variant of rs35054928. The risk alleles were preferentially found in open chromatin and bound by Ser5 phosphorylated RNA polymerase II, suggesting that the risk alleles are associated with changes in transcription. Chromatin conformation capture demonstrated that the risk region was able to interact with the promoter of FGFR2, the likely target gene of this risk region. A role for FOXA1 in mediating breast cancer susceptibility at this locus is consistent with the finding that the FGFR2 risk locus primarily predisposes to estrogen-receptor-positive disease.